• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
TechBrainstorm Health

Why You Might Not Want to Be Tested for the Alzheimer’s Gene

Barb Darrow
By
Barb Darrow
Barb Darrow
Down Arrow Button Icon
Barb Darrow
By
Barb Darrow
Barb Darrow
Down Arrow Button Icon
November 2, 2016, 1:26 PM ET

More than 5 million Americans live with Alzheimer’s Disease, the sixth largest cause of death in this country. Given that, should you be tested for a gene that would show you to have a predisposition to Alzheimer’s?

Perhaps surprisingly, Dr. Richard Caselli, a top neurologist speaking a t Coins2Day’s Brainstorm Health conference, thinks not.

“My personal opinion? The short answer is no,” he said in response to a question from Dr. Sanjay Gupta, neurologist and CNN’s chief medical correspondent on Wednesday. “The longer answer depends on context.”

About 20% to 25% of North Americans carry this particular gene—the percentage varies by geography, he noted. That’s a significant number. But the issue with Alzheimer’s is that, thus far, a discovery of the gene that would indicate a higher probability of getting Alzheimer’s between the ages of 75 and 85 wouldn’t influence therapy or treatment, he warned.

Get Coins2Day’s Brainstorm Health newsletter.

It would be a different story if genetic testing could lead to treatment that would forge a better outcome, he said. But Alzheimer’s testing won’t really improve the subject’s quality of life.

“What are you going to do? Tell people not to have kids because they’ll get Alzheimer’s when they’re 75 years old?” Caselli asked.

Another panelist, Dr. Mary Lou Jepson, a former top technologist at Google (GOOG) and Facebook (FB) and now chief executive of Open Water, disagreed. Jepson said she has been tested. “Why wouldn’t I want to know?” She asked.

She may have a different perspective based on her personal experience. Twenty-one years ago when she was in college, Jepson was afflicted with a mystery illness that put her in a wheelchair and covered her in sores. The cause turned out to be an undiagnosed brain tumor. Luckily, someone spotted the bill for an MRI (magnetic resonance imaging) scan, which led to life-saving surgery.

In her case, early detection definitely led to better quality of life. Her startup, not coincidentally, aims to bring MRI technology, now available only from million-dollar room-sized machines, to the masses in portable form.

About the Author
Barb Darrow
By Barb Darrow
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.